Related Experiment Video
Updated: May 25, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion
Florence Grise1, Sandra Sena, Aurélien Bidaud-Meynard
1INSERM, Physiopathologie du Cancer du Foie, U1053, Bordeaux, France.
Unlabelled:
We performed a review of public microarray data that revealed a significant down-regulation of Rnd3 expression in hepatocellular carcinoma (HCC), as compared to nontumor liver. Rnd3/RhoE is an atypical RhoGTPase family member because it is always under its active GTP-bound conformation and not sensitive to classical regulators. Rnd3 down-regulation was validated by quantitative real-time polymerase chain reaction in 120 independent tumors. Moreover, Rnd3 down-expression was confirmed using immunohistochemistry on tumor sections and western blotting on human tumor and cell-line extracts. Rnd3 expression was significantly lower in invasive tumors with satellite nodules. Overexpression and silencing of Rnd3 in Hep3B cells led to decreased and increased three-dimensional cell motility, respectively. The short interfering RNA-mediated down-regulation of Rnd3 expression induced a loss of E-cadherin at cell-cell junctions that was linked to epithelial-mesenchymal transition through the up-regulation of the zinc finger E-box binding homeobox protein, ZEB2, and the down-regulation of miR-200b and miR-200c. Rnd3 knockdown mediated tumor hepatocyte invasion in a matrix-metalloproteinase-independent, and Rac1-dependent manner.
Conclusion:
Rnd3 down-regulation provides an invasive advantage to tumor hepatocytes, suggesting that RND3 might represent a metastasis suppressor gene in HCC.
Insights
Rnd3 (RhoE) expression is significantly reduced in hepatocellular carcinoma (HCC). This down-regulation promotes tumor cell invasion and metastasis, indicating Rnd3 may act as a metastasis suppressor gene in HCC.
Area of Science:
- Molecular biology
- Oncology
- Cell biology
Background:
- Rnd3 (RhoE) is an atypical Rho GTPase.
- Rnd3 expression is altered in hepatocellular carcinoma (HCC).
Purpose of the Study:
- To investigate the role of Rnd3 in HCC progression.
- To determine the functional impact of Rnd3 down-regulation on tumor cell behavior.
Main Methods:
- Analysis of public microarray data.
- Quantitative real-time polymerase chain reaction (qRT-PCR).
- Immunohistochemistry and western blotting.
- Cell culture experiments with Rnd3 overexpression and silencing.
- Short interfering RNA (siRNA) mediated gene knockdown.
Main Results:
- Rnd3 expression is significantly down-regulated in HCC compared to non-tumor liver tissue.
- Lower Rnd3 expression correlates with invasive HCC tumors and satellite nodules.
- Rnd3 manipulation affects 3D cell motility; knockdown increases invasion.
- Rnd3 down-regulation is linked to epithelial-mesenchymal transition (EMT) via ZEB2 and miR-200b/c.
- Rnd3 knockdown-induced invasion is Rac1-dependent and matrix-metalloproteinase-independent.
Conclusions:
- Rnd3 down-regulation confers an invasive advantage to HCC hepatocytes.
- Rnd3 functions as a potential metastasis suppressor gene in HCC.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Regulation of Angiogenesis and Blood Supply
Cell Polarization by Rho Proteins

